In the rush to bring CBD products to retail, manufacturers have been found wanting according to FDA standards. In a statement released in late November, the Food and Drug Administration weighed in on their current stance regarding cannabidiol, thc and the marketing of CBD products as a dietary supplement. And to be completely honest, it wasn’t pretty.
As it currently stands, the U.S. Food and Drug Administration has currently approved only one CBD product, which is actually a prescription drug created to treat epilepsy. In their consumer update, the FDA made it clear that it is illegal to market CBD products by either adding cannabidiol to food or labeling them as a dietary supplement.
The Risk of Using CBD Products
The FDA made it a point to remind consumers that the use of CBD carries risks and that some products are being marketed with health claims that are not approved by the Food and Drug Administration. In a bullet-pointed list, the FDA pointed out that the use of CBD products could result in liver injury and might negatively impact the metabolism of other prescription drugs that a person may currently be taking for other health issues.
This consumer update also detailed a comprehensive list of unknowns including the long-term effects of cbd use, the impact of cannabidiol on a growing fetus and the unknown affects that cbd products can have on a developing brain.
Despite how many health benefits have been cited through research in the last year or so, the FDA‘s consumer update is a word of caution for those using products containing cbd oil, thc and the like. Currently, products containing CBD, from hemp oil to gummies and other cannabis products are still under investigation by the Food and Drug Administration, unanswered questions regarding safety concerns take top priority with the government administration and they have promised to continue looking into this matter to educate Americans and continue to caution them of the side effects and other safety concerns that could arise from the use of cbd products.
Proceed with Caution
Although the Farm Bill removed hemp, defined as cannabis products and cannabis derivatives from the definition of marijuana of the Controlled Substances Act, CBD products are still subject to all applicable FDA laws regarding products that contain any other substance. The FDA’s stance on CBD products is remaining firm, and it’s all for the benefit of public health and safety.
Though there’s currently a gray area, the word of caution is to create and use CBD products at your own risk. The Food and Drug Administration is unapologetic in their consumer updates for good reason. The Farm Bill has moved this trend so far, but the FDA isn’t concerned about trends more than they are about the safety concerns they have about Americans and their use of cbd. Stay tuned.